A Genetic Risk Nomogram for Patients With Colorectal Liver Metastases: The Central Role of BRAF Mutational Status in Stratifying Outcomes

HPB - United Kingdom
doi 10.1016/j.hpb.2018.02.053
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Systematic Review of a Liver‐first Approach in Patients With Colorectal Cancer and Synchronous Colorectal Liver Metastases

HPB
HepatologyGastroenterology
2014English

Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes

Clinical Colorectal Cancer
OncologyGastroenterology
2015English

The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases

Canadian Journal of Gastroenterology and Hepatology
MedicineHepatologyGastroenterology
2018English

Second and Third Laparoscopic Liver Resection for Patients With Recurrent Colorectal Liver Metastases

HPB
HepatologyGastroenterology
2016English

Two-Stage Strategy for Patients With Extensive Bilateral Colorectal Liver Metastases

HPB
HepatologyGastroenterology
2010English

Colorectal Liver Metastases – Enhancing Outcomes Through Combination Treatments

European Oncology and Haematology
OncologyHematology
2008English

Indeterminate Pulmonary Nodules in Colorectal Liver Metastases: A Comparison of Patient Outcomes

HPB
HepatologyGastroenterology
2016English

Evaluation of Peri-Operative Chemotherapy Using a Prognostic Nomogram for Survival After Resection of Colorectal Liver Metastases

HPB
HepatologyGastroenterology
2009English

Administered Activity and Outcomes of Glass Versus Resin 90Y Microsphere Radioembolization in Patients With Colorectal Liver Metastases

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy